Related Experiment Videos
Potent analgetics derived from 9-nor-9 beta-hydroxyhexahydrocannabinol
NIDA Research Monograph
|February 1, 1981
Summary
Researchers modified the C-3 side chain of 9-nor-9 beta-hydroxyhexahydrocannabinol (HHC) to enhance its pain-relieving effects. Some derivatives showed significantly greater analgesic activity than morphine, offering potential for novel, non-opioid pain treatments.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Synthesis
Background:
- 9-nor-9 beta-hydroxyhexahydrocannabinol (HHC) exhibits morphine-like analgesic properties.
- Optimizing HHC's structure could lead to potent, non-opioid analgesics.
- The C-3 side chain is a key area for structural modification.
Purpose of the Study:
- To investigate the structure-activity relationship of HHC derivatives by modifying the C-3 side chain.
- To identify HHC analogs with enhanced analgesic potency compared to morphine.
- To explore novel non-opioid analgesic candidates.
Main Methods:
- Synthesis of four distinct classes of HHC derivatives with varied C-3 side chains: alkyl, arylalkyl, alkoxy, and arylalkyloxy.
- Evaluation of the analgesic activity of synthesized HHC derivatives.
- Comparative analysis of analgesic potency against morphine.
Main Results:
- Three HHC derivatives (lb, lf, ll) demonstrated analgesic activity approximately 10 times that of morphine.
- The analgesic activity was dependent on the specific structure of the C-3 side chain.
- The 1-methyl-4-phenylbutyloxy side chain exhibited a unique effect on analgesic potency.
Conclusions:
- Structural modification of the C-3 side chain of HHC can yield potent, non-opioid analgesics.
- HHC derivatives represent a promising class of compounds for developing novel pain management therapies.
- Further research into the unique properties of specific side chains, like 1-methyl-4-phenylbutyloxy, is warranted.